Product Information
TRI-MILI 28 TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1268 per EA under NDC 65862077728. Its NADAC has been published 201 times since Oct 19, 2022.
FDA first approved this application on Jul 6, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Aurobindo Pharma LimitedNDC
65862077728
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA205441FDA Approved
7/6/2016
TE Code
AB
On Market Since
7/6/2016
Price Statistics
The NADAC for TRI-MILI 28 TABLET has been published 201 times since Oct 19, 2022, and over the history we have for it it has declined 24.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1268 per EA |
|---|---|
| All-time high | $0.1684 (Nov 16, 2022) |
| All-time low | $0.1072 (Jul 17, 2024) |
| 52-week high | $0.1375 |
| 52-week low | $0.1259 |
| Median price | $0.1346 |
| Average price | $0.1344 |
| Largest weekly change | -19.9% (Jul 17, 2024) |
| Weeks tracked | 201 |
| Tracking since | Oct 19, 2022 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TRI-MILI 28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRI-MILI 28 TABLET, manufactured by Aurobindo Pharma Limited, is $0.1268 per EA (NDC 65862077728), effective Aug 19, 2026.
How has the price of TRI-MILI 28 TABLET changed over time?
Over the history we have for it, the NADAC for TRI-MILI 28 TABLET has declined 24.7%. It has been tracked across 201 weekly CMS publications since Oct 19, 2022.
What are the highest and lowest recorded NADAC prices for TRI-MILI 28 TABLET?
Since Oct 19, 2022, the NADAC for TRI-MILI 28 TABLET has ranged from a low of $0.1072 (Jul 17, 2024) to a high of $0.1684 (Nov 16, 2022), with a median of $0.1346 per EA.
Are there cheaper alternatives to TRI-MILI 28 TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRI-VYLIBRA LO TABLET, is $0.1083 per EA — about 15% below TRI-MILI 28 TABLET.
Who manufactures TRI-MILI 28 TABLET?
TRI-MILI 28 TABLET (NDC 65862077728) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.